Concord Biotech Share Price
Small Cap | Pharmaceuticals and health care | NSE: CONCORDBIO | BSE: 543960
₹1,656.65 -64.20 (-3.73 %)
Last Updated: 04 Apr 2025 03:52 PM
Overview
Open (₹) 1,736.00
High (₹) 1,736.00
Low (₹) 1,636.55
Prev. Close (₹) 1,720.85
Volume 45,652
VWAP (₹) 1,506.13
ROCE (%) 26.41
Industry P/E 44.73
TTM P/E 53.11
P/B Ratio 11.35
Market Cap (₹) Cr.17,331.24
Dividend Yield (%)0.53
EPS (₹) 29.45
ROE20.18%
Sales Growth (%) 19.20
Profit Growth (%)27.97
Day Range
1,736.001,736.00
52 Week Range
1,326.902,658.00
Historical Returns
Returns (6M)
-9.82 %
Returns (1Y)
7.83 %
Returns (3Y)
75.72 %
Returns (5Y)
75.72 %
Returns (6M)
-9.82 %
Returns (1Y)
7.83 %
Returns (3Y)
75.72 %
Returns (5Y)
75.72 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (28.32%) TTM EPS Growth
- Company with no debt
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 28.32% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 41.48
MFI 15.69
ATR 150.79
Commodity Channel Index -101.80
ROC125 -12.28
ROC21 -27.60
Williams %R -98.35
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 1,555.41 | 1,614.73 | 1,652.41 | 1,517.73 | 1,458.41 | 1,420.73 | 1,361.41 |
Week Ago | 1,684.76 | 1,719.33 | 1,745.71 | 1,658.38 | 1,623.81 | 1,597.43 | 1,562.86 |
Month Ago | 2,112.41 | 2,181.63 | 2,265.31 | 2,028.73 | 1,959.51 | 1,875.83 | 1,806.61 |
EMA & SMA
1656.65
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
15
5 Day 1623.70
9 Day 1656.47
10 Day 1661.14
12 Day 1814.61
14 Day 1854.27
20 Day 1945.13
26 Day 1970.48
50 Day 2068.84
100 Day 2012.01
200 Day 1845.02
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
UBS PRINCIPAL CAPITAL ASIA LIMITED | bulk | Sell | 20 Sept, 2024 | ₹2,589.86 | 7,40,159 | NSE |
THE VANGUARD GROUP INC A/C VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | bulk | Buy | 20 Sept, 2024 | ₹2,596.08 | 6,97,936 | NSE |
THE VANGUARD GROUP INC A/C VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNAT | bulk | Buy | 20 Sept, 2024 | ₹2,596.08 | 5,77,183 | NSE |
1575773 ONTARIO INC | bulk | Sell | 28 May, 2024 | ₹1,361.26 | 35,48,211 | NSE |
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | bulk | Buy | 28 May, 2024 | ₹1,386.95 | 6,00,000 | NSE |
NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Sell | 18 Aug, 2023 | ₹930.55 | 11,31,896 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 18 Aug, 2023 | ₹935.55 | 7,35,455 | NSE |
NORGES BANK ON ACCOUNT OF THE GOVERNMENT PENSION FUND GLOBAL | bulk | Buy | 18 Aug, 2023 | ₹900.05 | 8,99,037 | NSE |
NK SECURITIES RESEARCH PRIVATE LIMITED | bulk | Buy | 18 Aug, 2023 | ₹930.12 | 11,31,896 | NSE |
GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 18 Aug, 2023 | ₹935.17 | 7,35,455 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
23 Sept, 2024 | Chandrashekhar Mukundrao Chawan | Disposal | ₹2,109.40 | 1,000 | NSE |
23 Sept, 2024 | Prakash Lalchand Sajnani | Disposal | ₹2,168.80 | 5,000 | NSE |
04 Sept, 2024 | Devang Bhatt | Disposal | ₹1,734.79 | 3,000 | NSE |
13 Jun, 2024 | Kanishka Kapoor | Disposal | ₹ | 10,000 | NSE |
05 Jun, 2024 | Ravi Kapoor | Disposal | ₹ | 10,000 | NSE |
27 Feb, 2024 | Rajendra Modi | Disposal | ₹1,499.52 | 4,000 | NSE |
27 Feb, 2024 | Raksha Modi | Disposal | ₹1,492.37 | 2,000 | NSE |
24 Feb, 2024 | Mr. Chandrashekhar Mukundrao Chawan | Disposal | ₹1,444.90 | 1,000 | NSE |
24 Feb, 2024 | Raksha Modi | Disposal | ₹1,466.52 | 2,000 | NSE |
22 Nov, 2023 | UTPAL SHETH | Acquisition | ₹1,231.02 | 253 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
23 May, 2024 | Rs.8.7500 per share(875%)Dividend | 21 Jun, 2024 | 22 Jun, 2024 |
Announcements
Date | Source | Detail |
---|---|---|
25 Mar, 2025 | NSE India | Concord Biotech Limited has informed the Exchange about Commencement of commercial production/operations |
25 Mar, 2025 | BSE India | Enclosed herewith announcement about successfully commissioned and commenced production of Injectable at our Manufacturing facility situated at Valthera. |
24 Mar, 2025 | NSE India | CONCORD BIOTECH LIMITED has informed the Exchange about Closure of Trading Window |
22 Mar, 2025 | NSE India | Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
18 Mar, 2025 | BSE India | Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 21st March 2025 in New york, USA. |
18 Mar, 2025 | NSE India | Concord Biotech Limited has informed the Exchange about Schedule of meet |
10 Mar, 2025 | NSE India | Concord Biotech Limited has informed the Exchange about Schedule of meet |
10 Mar, 2025 | BSE India | Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 scheduled on 13th March, 2025 at 8:45 AM |
04 Mar, 2025 | NSE India | CONCORD BIOTECH LIMITED has informed the Exchange regarding Acquisition |
04 Mar, 2025 | NSE India | Concord Biotech Limited has informed the Exchange regarding Outcome of Board Meeting held on March 04, 2025. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 25 Jan, 2025 | 13 Feb, 2025 |
Quarterly Results | -- | 07 Nov, 2024 | 11 Nov, 2024 |
Quarterly Results | -- | 01 Aug, 2024 | 09 Aug, 2024 |
Audited Results & Dividend | -- | 16 May, 2024 | 23 May, 2024 |
Quarterly Results | -- | 31 Jan, 2024 | 08 Feb, 2024 |
Quarterly Results | -- | 26 Oct, 2023 | 08 Nov, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | |||
---|---|---|---|---|---|
Promoter Group | 44.08% | 44.08% | 0% | 0% | 0% |
Foreign Institutions + | 8.33% | 7% | 0% | 0% | 0% |
Domestic Institutions + | 9.65% | 8.46% | 0% | 0% | 0% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 37.94% | 40.46% | 0% | 0% | 0% |
Others | 0% | 0% | 0% | 0% | 0% |
About Concord Biotech
Concord Biotech is a Public Limited Listed company incorporated on 23/11/1984 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1984PLC007440 and registration number is 007440. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1016.94 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Herren Group
Founded
1984
Managing Director
Mr. Sudhir Vaid
NSE Symbol
CONCORDBIO
Concord Biotech Management
Name | Designation |
---|---|
Mr. Sudhir Vaid | Chairman & Managing Director |
Mr. Ankur Vaid | Joint Managing Director & CEO |
Mr. Ravi Kapoor | Non Executive Director |
Mr. Rajiv Ambrish Agarwal | Non Executive Director |
Mrs. Bharti Khanna | Independent Director |
Mr. Amitabh Thakore | Independent Director |
Mr. Arvind Agarwal | Independent Director |
Mr. Jayaram Easwaran | Independent Director |
Dr. Mandayam Chakravarthy Sriraman | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35 ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50 ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Concord Biotech
What is the share price of Concord Biotech?
The share price of Concord Biotech on 04 Apr, 2025 is ₹ 1,656.65.
What is 52W high and 52W low share price of Concord Biotech?
The highest and lowest 52W share prices of Concord Biotech are ₹ 2658.000 and ₹ 1326.900
What is the market cap of Concord Biotech?
The market capitalization of Concord Biotech as of 04 Apr, 2025 is ₹ 17,331.24 Crores
What is the P/E ratio of Concord Biotech?
The current P/E ratio of Concord Biotech as of 04 Apr, 2025 is 44.73
What is the PB ratio of Concord Biotech?
The PB ratio of Concord Biotech as of 04 Apr, 2025 is 11.35
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)